Literature DB >> 22660520

Polymorphism 677C → T MTHFR gene in Mexican mothers of children with complex congenital heart disease.

Norma A Balderrábano-Saucedo1, Rocio Sánchez-Urbina, José A Sierra-Ramírez, Normand García-Hernández, Adriana Sánchez-Boiso, Miguel Klunder-Klunder, Diego Arenas-Aranda, Gabriela Bravo-Hernández, Penelope Noriega-Zapata, Alfredo Vizcaíno-Alarcón.   

Abstract

Congenital heart defects (CHD) are the third leading cause of death in children <1 year of age in Mexico where there is a high prevalence of the 677C → T polymorphism of the MTHFR gene. This is important because the homozygous 677T/T MTHFR gene and deficiency of folic acid (FA) intake have been associated with CHD. Our objective was to analyze the possible association between the genotype 677T/T of the MTHFR gene and supplementation of FA in Mexican women with the presence of complex CHD in their children. We analyzed genotypes of 31 mothers of children with complex CHD (group I) and 62 mothers of healthy children (group II) and investigated FA supplementation during pregnancy in both study groups. Allele frequencies in group I were 41.9 % for C and 58.1 % for T and 22.6 % for genotype frequencies CC, 38.7 % for CT, and 38.7 % for TT. Allele frequencies in group II were 63.7 % for C and 36.3 % for T and 38.7 % for genotype frequencies CC, 50 % for CT and 11.3 % for TT. Both populations are in Hardy-Weinberg equilibrium. Odds ratio for having a child with a complex CHD was 5.9, p = 0.008 (95 % CI 1.67; 20.63) for the TT genotype. FA supplementation at any time during pregnancy was 90.3 and 87.9 % in groups II and I respectively (p > 0.05). Association was found between the maternal genotype (677/TT MTHFR) with the presence of complex CHD in their offspring. No differences in FA supplementation during any stage were found between groups.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22660520     DOI: 10.1007/s00246-012-0380-y

Source DB:  PubMed          Journal:  Pediatr Cardiol        ISSN: 0172-0643            Impact factor:   1.655


  37 in total

Review 1.  Epidemiology of cardiovascular malformations: prevalence and risk factors.

Authors:  C A Loffredo
Journal:  Am J Med Genet       Date:  2000

2.  Maternal and offspring MTHFR gene C677T polymorphism as predictors of congenital atrial septal defect and patent ductus arteriosus.

Authors:  Wenli L Zhu; Yong Li; Liying Yan; Jingjing Dao; Shuqin Li
Journal:  Mol Hum Reprod       Date:  2005-12-22       Impact factor: 4.025

3.  Periconceptional multivitamin use and the occurrence of conotruncal heart defects: results from a population-based, case-control study.

Authors:  L D Botto; M J Khoury; J Mulinare; J D Erickson
Journal:  Pediatrics       Date:  1996-11       Impact factor: 7.124

4.  Association between 5,10-methylenetetrahydrofolate reductase C677T and A1298C polymorphisms and conotruncal heart defects.

Authors:  Simona Storti; Simona Vittorini; Maria R Iascone; Monica Sacchelli; Anita Collavoli; Andrea Ripoli; Guido Cocchi; Andrea Biagini; Aldo Clerico
Journal:  Clin Chem Lab Med       Date:  2003-03       Impact factor: 3.694

5.  Homocysteine induces congenital defects of the heart and neural tube: effect of folic acid.

Authors:  T H Rosenquist; S A Ratashak; J Selhub
Journal:  Proc Natl Acad Sci U S A       Date:  1996-12-24       Impact factor: 11.205

6.  Association of congenital cardiovascular malformations with 33 single nucleotide polymorphisms of selected cardiovascular disease-related genes.

Authors:  Karen Kuehl; Christopher Loffredo; Edward J Lammer; David M Iovannisci; Gary M Shaw
Journal:  Birth Defects Res A Clin Mol Teratol       Date:  2010-02

7.  A cost-effectiveness analysis of folic acid fortification policy in the United States.

Authors:  Tanya Gk Bentley; Milton C Weinstein; Walter C Willett; Karen M Kuntz
Journal:  Public Health Nutr       Date:  2008-07-01       Impact factor: 4.022

8.  Cost-effectiveness of mandatory folate fortification v. other options for the prevention of neural tube defects: results from Australia and New Zealand.

Authors:  Kim Dalziel; Leonie Segal; Rachelle Katz
Journal:  Public Health Nutr       Date:  2009-09-17       Impact factor: 4.022

9.  Birth of a new program in Mexico City: the Kardias experience.

Authors:  Alexis Palacios-Macedo
Journal:  Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu       Date:  2008

10.  Prevalence of severe congenital heart disease after folic acid fortification of grain products: time trend analysis in Quebec, Canada.

Authors:  Raluca Ionescu-Ittu; Ariane J Marelli; Andrew S Mackie; Louise Pilote
Journal:  BMJ       Date:  2009-05-12
View more
  9 in total

1.  The association of the MTHFR c.1625A>C genetic variant with the risk of congenital heart diseases in the Chinese.

Authors:  Yuting Wang; Lei Sun; Weina Du; Shuang Song; Shuo Wang; Weiju Jiang; Tianchu Huang; Hui Li
Journal:  Genet Test Mol Biomarkers       Date:  2015-01

2.  Association between MTHFR polymorphisms and congenital heart disease: a meta-analysis based on 9,329 cases and 15,076 controls.

Authors:  Chao Xuan; Hui Li; Jin-Xia Zhao; Hong-Wei Wang; Yi Wang; Chun-Ping Ning; Zhen Liu; Bei-Bei Zhang; Guo-Wei He; Li-Min Lun
Journal:  Sci Rep       Date:  2014-12-04       Impact factor: 4.379

3.  Association between 5, 10-methylenetetrahydrofolate reductase (MTHFR) polymorphisms and congenital heart disease: A meta-analysis.

Authors:  Wenju Wang; Zongliu Hou; Chunhui Wang; Chuanyu Wei; Yaxiong Li; Lihong Jiang
Journal:  Meta Gene       Date:  2013-10-28

4.  Are polymorphisms in MTRR A66G and MTHFR C677T genes associated with congenital heart diseases in Iranian population?

Authors:  Noormohammad Noori; Ebrahim Miri-Moghaddam; Asieh Dejkam; Yasman Garmie; Ali Bazi
Journal:  Caspian J Intern Med       Date:  2017

5.  MTHFR Gene Mutations Correlate with White Matter Disease Burden and Predict Cerebrovascular Disease and Dementia.

Authors:  Christian E Cajavilca; Rajan R Gadhia; Gustavo C Román
Journal:  Brain Sci       Date:  2019-08-22

6.  Association of methylenetetrahydrofolate reductase gene polymorphisms and maternal folic acid use with the risk of congenital heart disease.

Authors:  Taowei Zhong; Xinli Song; Yiping Liu; Mengting Sun; Senmao Zhang; Letao Chen; Jingyi Diao; Jinqi Li; Yihuan Li; Jing Shu; Jianhui Wei; Ping Zhu; Tingting Wang; Jiabi Qin
Journal:  Front Pediatr       Date:  2022-09-08       Impact factor: 3.569

7.  Maternal Hypertension-Related Genotypes and Congenital Heart Defects.

Authors:  Yunping Lei; Katherine L Ludorf; Xiao Yu; Renata H Benjamin; Xue Gu; Ying Lin; Richard H Finnell; Laura E Mitchell; Fadi I Musfee; Sadia Malik; Mark A Canfield; Alanna C Morrison; Charlotte A Hobbs; Alissa R Van Zutphen; Sarah Fisher; A J Agopian
Journal:  Am J Hypertens       Date:  2021-02-18       Impact factor: 2.689

8.  Maternal Folic Acid Intake and Methylation Status of Genes Associated with Ventricular Septal Defects in Children: Case-Control Study.

Authors:  Sandra M González-Peña; Geovana Calvo-Anguiano; Laura E Martínez-de-Villarreal; Patricia R Ancer-Rodríguez; José J Lugo-Trampe; Donato Saldivar-Rodríguez; María D Hernández-Almaguer; Melissa Calzada-Dávila; Ligia S Guerrero-Orjuela; Luis D Campos-Acevedo
Journal:  Nutrients       Date:  2021-06-17       Impact factor: 5.717

9.  Evaluation of High Resolution Melting for MTHFR C677T Genotyping in Congenital Heart Disease.

Authors:  Ying Wang; Haiyan Zhang; Shuying Yue; Kun Zhang; Hui Wang; Rui Dong; Xiaomeng Yang; Yi Liu; Yanhui Ma
Journal:  PLoS One       Date:  2016-03-18       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.